• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非裔美国人中肥厚性瘢痕的发病率与维生素D-3代谢有关吗?

Incidence of hypertrophic scars among African Americans linked to vitamin D-3 metabolism?

作者信息

Cooke Gerald L, Chien Anna, Brodsky Amy, Lee Raphael C

机构信息

Department of Surgery, Medicine and Organismal Biology & Anatomy, Pritzker School of Medicine, The University of Chicago, Chicago, IL 60637, USA.

出版信息

J Natl Med Assoc. 2005 Jul;97(7):1004-9.

PMID:16080671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2569323/
Abstract

The pathogenesis and progression of wound-healing involve intricate pathways and numerous chemical mediators. This remains an area of intense study as undesirable results of this process, such as hypertrophic scars and keloids, can result in significant morbidity. These lesions are distinct in their characteristics, although they are similar in their distribution in patients with darker skin colors. There is a robust inflammatory mechanism behind the formation of hypertrophic scars and keloids. Furthermore, their development may be intimately related to vitamin D-3, which has been shown to be a powerful anti-inflammatory agent. This chemical is made in the skin, whose production is influenced by various factors of which the amount of melanin is a crucial one. More specifically, an increase in pigmentation has been shown to decrease the amount of vitamin D-3 synthesis in the skin. Thus, this paper proposes the hypothesis linking the propensity of inflammation and subsequent scarring in darker-skinned individuals to the reduced levels of vitamin D-3 production in their skin.

摘要

伤口愈合的发病机制和进展涉及复杂的途径和众多化学介质。这仍是一个深入研究的领域,因为这一过程的不良结果,如增生性瘢痕和瘢痕疙瘩,会导致显著的发病率。这些病变在特征上有所不同,尽管它们在肤色较深的患者中的分布相似。增生性瘢痕和瘢痕疙瘩的形成背后存在强大的炎症机制。此外,它们的发展可能与维生素D-3密切相关,维生素D-3已被证明是一种强大的抗炎剂。这种化学物质在皮肤中产生,其生成受多种因素影响,其中黑色素的量是关键因素之一。更具体地说,色素沉着增加已被证明会减少皮肤中维生素D-3的合成量。因此,本文提出了一个假说,将肤色较深个体的炎症倾向及随后的瘢痕形成与他们皮肤中维生素D-3生成水平降低联系起来。

相似文献

1
Incidence of hypertrophic scars among African Americans linked to vitamin D-3 metabolism?非裔美国人中肥厚性瘢痕的发病率与维生素D-3代谢有关吗?
J Natl Med Assoc. 2005 Jul;97(7):1004-9.
2
Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.内皮功能障碍可能在瘢痕疙瘩和增生性瘢痕的发病机制中起关键作用——瘢痕疙瘩和增生性瘢痕可能是血管性疾病。
Med Hypotheses. 2016 Nov;96:51-60. doi: 10.1016/j.mehy.2016.09.024. Epub 2016 Sep 28.
3
New insights on keloids, hypertrophic scars, and striae.增生性瘢痕、瘢痕疙瘩和妊娠纹的新认识。
Dermatol Clin. 2014 Apr;32(2):193-209. doi: 10.1016/j.det.2013.11.002.
4
Mechanobiology and force transduction in scars developed in darker skin types.
Skin Res Technol. 2006 Nov;12(4):279-82. doi: 10.1111/j.0909-752X.2006.00165.x.
5
Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.评估口服异维A酸对瘢痕疙瘩和增生性瘢痕影响的观察性回顾性研究。
Int J Dermatol. 2016 Nov;55(11):1255-1258. doi: 10.1111/ijd.13317.
6
Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?增生性瘢痕:维生素和炎症生物标志物与伤口愈合的病理生理学有关吗?
Obes Surg. 2017 Dec;27(12):3170-3178. doi: 10.1007/s11695-017-2740-4.
7
Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.瘢痕疙瘩和增生性瘢痕是网状真皮层慢性炎症的结果。
Int J Mol Sci. 2017 Mar 10;18(3):606. doi: 10.3390/ijms18030606.
8
Keloids and hypertrophic scars: are they two different sides of the same coin?瘢痕疙瘩与增生性瘢痕:它们是同一硬币的两面吗?
Dermatol Surg. 2008 Mar;34(3):336-46. doi: 10.1111/j.1524-4725.2007.34067.x. Epub 2007 Dec 19.
9
Keloids and ultrasound detected fibroids in young African American women.年轻非裔美国女性中的瘢痕疙瘩和超声检测到的纤维瘤。
PLoS One. 2013 Dec 27;8(12):e84737. doi: 10.1371/journal.pone.0084737. eCollection 2013.
10
Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.肥厚性瘢痕和瘢痕疙瘩——关于其病理生理学、危险因素及治疗管理的综述
Dermatol Surg. 2009 Feb;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x.

引用本文的文献

1
Serum Vitamin D Levels and Its Relationship With Keloid, Acne or Hypertrophic Scar: A Two-Sample Mendelian Randomization Study.血清维生素D水平及其与瘢痕疙瘩、痤疮或增生性瘢痕的关系:一项两样本孟德尔随机化研究。
J Cosmet Dermatol. 2025 Aug;24(8):e70398. doi: 10.1111/jocd.70398.
2
Evidence-Based Topical Therapy for Facial Scars in Diverse Skin Types.不同皮肤类型面部瘢痕的循证局部治疗
Cureus. 2025 Jun 19;17(6):e86343. doi: 10.7759/cureus.86343. eCollection 2025 Jun.
3
Pharmacotherapy for Keloids and Hypertrophic Scars.瘢痕疙瘩和增生性瘢痕的药物治疗。
Int J Mol Sci. 2024 Apr 25;25(9):4674. doi: 10.3390/ijms25094674.
4
In-depth examination of hyperproliferative healing in two breeds of commonly used for research.深入研究两种常用于研究的常见品种的过度增生性愈合。
Animal Model Exp Med. 2021 Nov 22;4(4):406-417. doi: 10.1002/ame2.12188. eCollection 2021 Dec.
5
Vitamin D Clinical Pharmacology: Relevance to COVID-19 Pathogenesis.维生素 D 临床药理学:与 COVID-19 发病机制的相关性。
J Natl Med Assoc. 2021 Apr;113(2):208-211. doi: 10.1016/j.jnma.2020.09.152. Epub 2020 Nov 2.
6
The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.瘢痕疙瘩疾病:异质性、组织病理学、机制与模型
Front Cell Dev Biol. 2020 May 26;8:360. doi: 10.3389/fcell.2020.00360. eCollection 2020.
7
High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars.瘢痕疙瘩和增生性瘢痕中的高迁移率族蛋白盒1、基质金属蛋白酶与维生素D
Plast Reconstr Surg Glob Open. 2015 Jul 8;3(6):e425. doi: 10.1097/GOX.0000000000000391. eCollection 2015 Jun.
8
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases.雷珠单抗治疗黑人人群新生血管性年龄相关性黄斑变性的视觉预后:5例报告
Clin Ophthalmol. 2010 Aug 19;4:913-6. doi: 10.2147/opth.s10259.

本文引用的文献

1
From scarless fetal wounds to keloids: molecular studies in wound healing.从胎儿无瘢痕伤口到瘢痕疙瘩:伤口愈合的分子研究
Wound Repair Regen. 2003 Nov-Dec;11(6):411-8. doi: 10.1046/j.1524-475x.2003.11604.x.
2
Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells.1,25-二羟基维生素D3对芥子气(HD)诱导人皮肤细胞产生白细胞介素-6和白细胞介素-8的调节作用
Pharmacol Toxicol. 2003 May;92(5):204-13. doi: 10.1034/j.1600-0773.2003.920503.x.
3
p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells.
Endocrinology. 2003 Jan;144(1):50-60. doi: 10.1210/en.2001-210109.
4
Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition.胎鼠无瘢痕修复的共聚焦显微镜分析:界定转变过程
Plast Reconstr Surg. 2002 Jan;109(1):160-70. doi: 10.1097/00006534-200201000-00026.
5
Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression.白细胞介素-6(IL-6)基因等位基因与系统性红斑狼疮(SLE)及IL-6表达升高的关联。
Genes Immun. 1999 Sep;1(1):45-52. doi: 10.1038/sj.gene.6363631.
6
Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.类风湿关节炎滑膜成纤维细胞中白细胞介素-6和白细胞介素-8表达的调控:核因子-κB起主导作用,而非C/EBPβ或c-Jun。
J Immunol. 2000 Dec 15;165(12):7199-206. doi: 10.4049/jimmunol.165.12.7199.
7
Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair.纤调蛋白(一种转化生长因子-β调节剂)在胎儿皮肤发育和无瘢痕修复中的差异表达。
Am J Pathol. 2000 Aug;157(2):423-33. doi: 10.1016/s0002-9440(10)64555-5.
8
Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair.在人类胎儿无瘢痕伤口修复过程中白细胞介素6(IL-6)产生减少。
Cytokine. 2000 Jun;12(6):671-6. doi: 10.1006/cyto.1999.0598.
9
Elevated interleukin-6 expression in keloid fibroblasts.
J Surg Res. 2000 Mar;89(1):74-7. doi: 10.1006/jsre.1999.5805.
10
Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children.7例儿童线状硬皮病采用口服1,25-二羟维生素D3(骨化三醇)治疗。
Pediatr Dermatol. 1999 Jan-Feb;16(1):53-8. doi: 10.1046/j.1525-1470.1999.99016.x.